SHANGHAI (Reuters) -Sanofi plans to invest around 1 billion euros ($1.05 billion) to build a new insulin production base in ...

Sanofi SA will invest around 1 billion euros ($1.1 billion) to build a new insulin production base in Beijing, its biggest ...

Sanofi just made its largest investment thus far in China. The company has committed just over $1 billion to build a new ...

Vice-Premier He Lifeng on Tuesday told Sanofi chairman Frédéric Oudéa that China will continue to improve its operating environment for businesses and welcome European firms in the country ...

Shortly after a similarly sized venture from Pfizer, French pharma juggernaut Sanofi has unveiled a major manufacturing ...

Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in ...

Sanofi has announced plans to invest approximately €1bn to build a new insulin production base in China.

The French pharma firm is seeking to increase insulin production in Beijing as trade tensions between the EU and China simmer ...

Sanofi (SNY) intends to spend about $1.05B building a new insulin manufacturing base in China, Kimberley Kao of The Wall Street Journal ...

France-based Sanofi S.A. (FR:SAN) is expanding its presence in China with an investment of €1 billion to build a new insulin manufacturing plant in Beijing. This represents Sanofi’s largest ...

Chinese authorities rolled out the red carpet for French pharmaceutical and healthcare giant Sanofi, which plans to invest ...

The site, which will be in the Beijing Economic and Technological Development Zone, will be Sanofi’s fourth production and supply base in China, Sanofi said in its official WeChat account.